These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 27045424)

  • 41. Microbiome-Modulated Metabolites at the Interface of Host Immunity.
    Blacher E; Levy M; Tatirovsky E; Elinav E
    J Immunol; 2017 Jan; 198(2):572-580. PubMed ID: 28069752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.
    Kanauchi O; Andoh A; Mitsuyama K
    J Agric Food Chem; 2013 Oct; 61(42):9977-83. PubMed ID: 24070265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastrointestinal Interaction between Dietary Amino Acids and Gut Microbiota: With Special Emphasis on Host Nutrition.
    Abdallah A; Elemba E; Zhong Q; Sun Z
    Curr Protein Pept Sci; 2020; 21(8):785-798. PubMed ID: 32048965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbes, metabolites, and the gut-lung axis.
    Dang AT; Marsland BJ
    Mucosal Immunol; 2019 Jul; 12(4):843-850. PubMed ID: 30976087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity.
    Meng X; Zhou HY; Shen HH; Lufumpa E; Li XM; Guo B; Li BZ
    Autoimmun Rev; 2019 May; 18(5):455-475. PubMed ID: 30844549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intestinal Permeability, Inflammation and the Role of Nutrients.
    Farré R; Fiorani M; Abdu Rahiman S; Matteoli G
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32340206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.
    Frosali S; Pagliari D; Gambassi G; Landolfi R; Pandolfi F; Cianci R
    J Immunol Res; 2015; 2015():489821. PubMed ID: 26090491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Gut Microbiota in Inflammatory Bowel Disease.
    Sheehan D; Shanahan F
    Gastroenterol Clin North Am; 2017 Mar; 46(1):143-154. PubMed ID: 28164847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The human gut microbiota and its interactive connections to diet.
    Milani C; Ferrario C; Turroni F; Duranti S; Mangifesta M; van Sinderen D; Ventura M
    J Hum Nutr Diet; 2016 Oct; 29(5):539-46. PubMed ID: 27161433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diet-microbiota-metabolite axis regulates the host physiology.
    Yamada T; Takahashi D; Hase K
    J Biochem; 2016 Jul; 160(1):1-10. PubMed ID: 26970281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bile Acid Signaling in Inflammatory Bowel Diseases.
    Fiorucci S; Carino A; Baldoni M; Santucci L; Costanzi E; Graziosi L; Distrutti E; Biagioli M
    Dig Dis Sci; 2021 Mar; 66(3):674-693. PubMed ID: 33289902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of intestinal microbiota and the immune system.
    Purchiaroni F; Tortora A; Gabrielli M; Bertucci F; Gigante G; Ianiro G; Ojetti V; Scarpellini E; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):323-33. PubMed ID: 23426535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota.
    Arboleya S; Bahrami B; Macfarlane S; Gueimonde M; Macfarlane GT; de los Reyes-Gavilán CG
    Benef Microbes; 2015; 6(4):543-52. PubMed ID: 25691102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
    Joyce SA; Gahan CG
    Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut.
    Fan P; Li L; Rezaei A; Eslamfam S; Che D; Ma X
    Curr Protein Pept Sci; 2015; 16(7):646-54. PubMed ID: 26122784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular interactions between the intestinal microbiota and the host.
    Hertli S; Zimmermann P
    Mol Microbiol; 2022 Jun; 117(6):1297-1307. PubMed ID: 35403275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbiota-stimulated immune mechanisms to maintain gut homeostasis.
    Chung H; Kasper DL
    Curr Opin Immunol; 2010 Aug; 22(4):455-60. PubMed ID: 20656465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.